| 证券代码 | KTOVW.O |
| 证券名称 | Kitov Pharma Ltd Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2015-11-20 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Purple Biotech Ltd. |
| 注册地址 | 以色列 |
| 办公地址 | One Azrieli Center, Round Tower, 23rd Floor, 132 Menachem Begin Road, Tel Aviv, Israel |
| 成立日期 | 1968-08-12 |
| 董事会主席 | - |
| 公司属地 | Israel 以色列 |
| 公司网址 | www.kitovpharma.com |
| 电话 | +972 (3) 933-3121 |
| 传真 | +972 (3) 509-7196 |
| 公司简介 | Purple Biotech Ltd. (Kitov Pharma Ltd.) is an innovative biopharmaceutical company focused on late-stage drug development. The company’s current product pipeline features two combination drugs intended to treat osteoarthritis pain and hypertension simultaneously. By lowering development risk and cost through streamlined regulatory approval of novel therapeutics, Kitov plans to delivers rapid ROI while making a meaningful impact on people’s lives. |